• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYBERONICS - HOUSTON PULSE GEN MODEL 1000; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYBERONICS - HOUSTON PULSE GEN MODEL 1000; GENERATOR Back to Search Results
Model Number 1000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Neck Pain (2433); Tissue Breakdown (2681)
Event Date 10/27/2018
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr?, code 81: device evaluation is not necessary as infection and other adverse events are not related to the functionality or delivery of therapy of the device.(b)(4).
 
Event Description
It was reported that the patient was hospitalized due to an infection, which led to the removal of their vns generator and a wound debridement.The patient's neurologist indicated that the reason for the generator pocket infection was unknown.It was reported that prior to generator explant, the generator was visible, likely due to the infection per the physician, and that the patient had a history of wound dehiscence, generator migration, and erosion through the skin.The patient's leads were initially left and the patient was treated with iv antibiotics for 10 weeks.The patient was hospitalized due to worsening condition of the neck area, that had began to drain due to infection, and the lead was infected and extruding through the skin as well.The patient additionally had a red "pimple-sized" bump at their neck incision site where the lead was coming through.The patient then had their vns leads removed on (b)(6) 2018 due to the reported infection and foreign body response.The patient had discomfort at their neck due to the reported lead extrusion.The patient had their vns electrodes removed on (b)(6) 2019 due to the infection, foreign body response, and discomfort at neck caused by the presence of the electrodes.A review of the device history records verified that the implanted products were sterilized and passed all functional specifications prior to distribution.Device evaluation is not necessary as infection and wound dehiscence is not related to the functionality or delivery of therapy of the device.No further relevant information has been received to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 1000
Type of Device
GENERATOR
Manufacturer (Section D)
CYBERONICS - HOUSTON
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
CYBERONICS - HOUSTON
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
rachel kohn
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key8506142
MDR Text Key141666900
Report Number1644487-2019-00699
Device Sequence Number1
Product Code LYJ
UDI-Device Identifier05425025750405
UDI-Public05425025750405
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date09/13/2019
Device Model Number1000
Device Lot Number204236
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Initial Date Manufacturer Received 03/20/2019
Initial Date FDA Received04/11/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age17 YR
-
-